Thursday, November 17, 2016

BRIEF-Prometic's PBI-4050 demonstrates early evidence of efficacy in its IPF Phase 2 clinical trial

* Early evidence of efficacy of PBI-4050 alone and also in

combination with one of commercially available IPF drugs

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)